Induction of MHC class I expression by the MHC class II transactivator CIITA

Immunity

Volumn 6, Issue 5, 1997, Pages 591-600

  Martin, Brian K ^a   Chin, Keh Chuang ^a   Olsen, John C ^a   Skinner, Cheryl A ^a   Dey, Anup ^b   Ozato, Keiko ^b   Ting, Jenny P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CELL LINE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TRANSACTIVATION;

EID: 0030982711     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80347-7     Document Type: Article

References (55)

1. Ausebel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Smith, J.A., Seidman, J.G., and Struhl, K. (1987). In: Current Protocols in Molecular Biology, F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman, and K. Struhl, eds. (New York: John Wiley), pp. 9.1.1-9.1.4.
2. Burke, P.A., and Ozato, K. (1989). Regulation of major histocompatibility complex class I genes. Year Immunol. 4, 23-40.
3. Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., and Flavell, R.A. (1996). Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4, 167-178.
4. Chang, C.H., Fontes, J.D., Peterlin, M., and Flavell, R.A. (1994). Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180, 1367-1374.
5. Chang, C.H., and Flavell, R. A. (1995). Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181, 765-767.
6. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellstrom, I., and Hellstrom, K.E. (1994). Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179, 523-532.
7. Chin, K.-C., Li, G.X., and Ting, J.P.-Y. (1997). Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the MHC class II transactivator (CIITA): generation of trans-dominant-negative mutants. Proc. Natl. Acad. Sci. USA 94, 2501-2506.
8. Chin, K.-C., Mao, C., Skinner, C., Riley, J.L., Wright, K.L., Moreno, C.S, Stark, G.R., Boss, J.M., and Ting, J.P.-Y. (1994). Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1, 687-697.
9. Cresswell, P. (1994). Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
10. Cromme, F.V., van Bommel, P.F., Walboomers, J.M., Gallee, M.P., Stern, P. L., Kenemans, P., Helmerhorst, T.J., Stukart, M.J., and Meijer, C.J. (1994). Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer 69, 1176-1181.
11. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82, 155-165.
12. Dever, T.E., Glynias, M.J., and Merrick, W.C. (1987). GTP-binding domain: three consensus sequence elements with distinct spacing. Proc. Natl. Acad. Sci. USA 84, 1814-1818.
13. Dey, A., Thornton, A.M., Lonergan, M., Weissman, S.M., Chamberlain, J.W., and Ozato, K. (1992). Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell Biol. 12, 3590-3599.
14. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA pol II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1488.
15. Dolo, V., Adobati, E., Canevari, S., Picone, M.A., and Vittorelli, M.L. (1995). Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin. Exp. Metastasis 13, 277-286.
16. Driggers, P.H., Elenbaas, B.A., An, J.B., Lee, I.J., and Ozato, K. (1992). Two upstream elements activate transcription of a major histocompatibility complex class I gene in vitro. Nucleic Acids Res. 20, 2533-2540.
17. Fehling, H.J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U., and von Boehmer, H. (1994). MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237.
18. Giuliani, C., Saji, M., Napolitano, G., Palmer, L.A., Taniguchi, S.I., Shong, M., Singer, D.S., and Kohn, L.D. (1995). Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-kappa B. J. Biol. Chem. 270, 11453-11462.
19. Glimcher, L.H., and Kara, C.J. (1992). Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10, 13-49.
20. Gobin, S.J.P., Peijnenburg, A., Keijsers, V., and van den Elsen, P.J. (1997). Site a is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6, this issue.
21. Israel, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. (1989). TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J. 8, 3793-3800.
22. Kara, C.J., and Glimcher, L.H. (1991). In vivo footprinting of MHC class II genes: Bare promoter in the bare lymphocyte syndrome. Science 252, 709-712.
23. Keating, P.J., Cromme, F.V., Duggan-Keen, M., Snijders, P.J., Walboomers, J.M., Hunter, R.D., Dyer, P.A., and Stern, P.L. (1995). Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer 72, 405-411.
24. Kern, I., Steimle, V., Siegrist, C.A., and Mach, B. (1995). The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7, 1295-1299.
25. Lee, K.A., and Masson, N.(1993). Transcriptional regulation by CREB and its relatives. Biochim. Biophys. Acta 1174, 221-233.
26. Mach, B. (1995). MHC class II regulation: lessons from a disease. N. Engl. J. Med. 332, 120-122.
27. Mach, B., Steimle, V., Martinez-Soria, E.,and Reith, W. (1996). Regulation of MHC class II genes: lessons from a disease. Annu. Rev. lmmunol. 14, 301-331.
28. Maguire, J.E., Frels, W.I., Richardson, J.C., Weissman, J.D., and Singer, D.S. (1992). In vivo function of regulatory DNA sequence elements of a major histocompatibility complex class I gene. Mol. Cell. Biol. 12, 3078-3086.
29. Mao, C., Davies, D., Kerr, I.M., and Stark, G.R. (1993). Mutant human cells defective in induction of major histocompatibility complex class Il genes by Interferon gamma. Proc. Natl. Acad. Sci. USA 90, 2880-2884.
30. Martin, B.K., and Weis, J.H. (1993). Functional identification of transcription control sequences of the mouse Crry gene. J. Immunol. 151, 857-869.
31. Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T.M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993). Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97.
32. Olsen, J.C., and Sechelski, J. (1995). Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther. 6, 1195-1202.
33. Ostrand-Rosenberg, S., Thakur, A., and Clements, V. (1990). Rejection of mouse sarcoma cells after transfection of M HC class II genes. J. Immunol. 144, 4068-4071.
34. Pulaski, B.A., McAdam, A.J., Hutter, E.K., Biggar, S., Lord, E.M., and Frelinger, J.G. (1993). Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 53, 2112-2117.
35. Ramirez, R., Solana, R., Carracedo, J., Alonso, M.C., and Pena, J. (1992). Mechanisms involved in NK resistance induced by interferon-gamma. Cell, Immunol. 140, 248-256.
36. Reis, L.F., Ruffner, H., Stark, G., Aguet, M., and Weissmann, C. (1994). Mice devoid of Interferon regulatory factor 1 (IRF-1) show normal expression of type I Interferon genes. EMBO J. 13, 4798-4806.
37. Restifo, N.P., Esquivel, F., Kawakami, Y., Yewdell, J.W., Mule, J.J., Rosenberg, SA, and Bennink, J.R. (1993). Identification of human cancers deficient in antigen processing. J. Exp. Med. 177, 265-272.
38. Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A., and Boss, J.M. (1995). Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2, 533-543.
39. Saji, M., Moriarty, J., Ban, T., Kohn, L.D., and Singer, D.S. (1992). Hormonal regulation of major histocompatibility complex class I genes in rat thyroid FRTL-5 cells: thyroid-stimulating hormone induces a cAMP-mediated decrease in class I expression. Proc. Natl. Acad. Sci. USA 89, 1944-1948.
40. Segars, J.H., Nagata, T., Bours, V., Medin, J.A., Franzoso, G.,Blanco, J.C., Drew, P.D., Seeker, K.G., An, J., Tang, T., et al. (1993). Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65)and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Mol. Cell Biol. 13, 6157-6169.
41. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
42. Sherman, P.A., Basta, P.V., and Ting, J.P.-Y. (1987). Upstream DNA sequences required for tissue-specific expression of the HLA-DRA gene. Proc. Natl. Acad. Sci. USA 84, 4254-4258.
43. Sherman, P.A., Basta, P.V., Heguy, A., Wloch, M.K., Roeder, R.G., and Ting, J.P.-Y. (1989). The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DRA gene promoter. Proc. Natl. Acad. Sci. USA 86, 6739-6743.
44. Shirayoshi, Y., Miyazaki, J., Burke, P.A., Hamada, K., Appella, E., and Ozato, K. (1987). Binding of multiple nuclear factors to the 5′ upstream regulatory element of the murine major histocompatibility class I gene. Mol. Cell Biol. 7, 4542-4548.
45. Singer, D.S., and Maguire, J.E. (1990). Regulation of the expression of class I MHC genes. Grit. Rev. Immunol. 10, 235-257.
46. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
47. Steimle, V., Often, L.A., Zufferey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
48. Steimle, V., Siegrist, C.A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994). Regulation of MHCclass II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265, 106-109.
49. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M.R., Mach, B., Reith, and W. (1995). A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9, 1021-1032.
50. Sugita, K., Miyazaki, J., Appella, E., and Ozato, K. (1987). Interferons increase transcription of a major histocompatibility class I gene via a 5′ Interferon consensus sequence. Mol. Cell. Biol. 7, 2625-2630.
51. Tatake, R.J., and Zeff, R.A. (1993). Regulated expression of the major histocompatibility complex class I genes. Proc. Soc. Exp. Biol. Med. 203, 405-417.
52. Ting, J.P.-Y., and Baldwin, A.S. (1993). Regulation of MHC gene expression. Curr. Opin. Immunol. 5, 8-16.
53. Vallejo, A.N., and Pease, L.R. (1995). Evolution of class I promoter sequences: relationship to function and diversity, Immunol. Rev. 143, 249-262.
54. Zhou, H., and Glimcher, L.H. (1995). Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2, 545-553.
55. Zijlstra, M., Bix, M., Simister, N.E., Loring, J.M., Raulet, D.H., and Jaenisch, R. (1990). Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344, 742-746.